Sundaresan S | Medicine | Best Researcher Award

Assoc Prof Dr. Sundaresan S | Medicine | Best Researcher Award

SRM Institute of Science and Technology, India

Author Profile

Early Academic Pursuits:

Dr. S. Sundaresan embarked on his academic journey with a strong foundation in Biochemistry, beginning with a Bachelor's degree from Annamalai University. He continued his pursuit of knowledge with a Master's degree and a subsequent M. Phil. in Biochemistry from the University of Madras. His academic journey culminated in a Ph.D. in Biochemistry from the University of Madras, where he laid the groundwork for his future endeavors in the field.

Professional Endeavors:

His professional journey commenced with a significant role as a Research Scientist at Annamalai University, where he contributed to a project sponsored by the National Institute of Health, USA. Subsequently, he held positions at various esteemed institutions, including Bharat Scans Pvt Ltd, IIBAT, and SRM MCH & RC, gaining diverse laboratory experience in Clinical Biochemistry and Biochemistry divisions. His roles included managing sophisticated laboratory equipment and supervising research activities.

Contributions and Research Focus:

His research interests primarily revolve around cancer chemoprevention, cancer immunotherapy, and tumor marker detection. Noteworthy contributions include the development of Andro/Evo-albumin nanoparticles loaded into polycaprolactone scaffolds, the study of tumor markers and gene expressions in hepatocellular carcinoma (HCC), and investigating the efficacy of various compounds for cancer prevention and treatment. His current focus lies in exploring the impact of probiotics on alleviating intestinal toxicity during cancer therapy.

Accolades and Recognition:

Throughout his illustrious career, He has garnered numerous awards and fellowships, underscoring his significant contributions to the field of Biochemistry and Cancer Research. Notable accolades include the Research Scientist Fellowship from NIH US Project, Young Scientist DST-Fast Track Award from DST New Delhi, and several research appreciation awards from SRM University. His exemplary research has also been recognized with paper presentation awards and medals.

Impact and Influence:

His research has had a profound impact on the understanding and treatment of cancer. His studies on cancer chemoprevention, tumor markers, and novel treatment modalities have expanded the horizons of cancer research, paving the way for innovative therapeutic strategies. Additionally, his mentorship of Ph.D. students and involvement in scholarly activities have nurtured the next generation of researchers, further extending his influence in the scientific community.

Legacy and Future Contributions:

His legacy is marked by his relentless pursuit of excellence in scientific research and his dedication to advancing the field of Biochemistry and Cancer Biology. As he continues his journey, he aims to further his investigations into cancer prevention, immunotherapy, and the therapeutic potential of probiotics. Through his ongoing efforts, Dr. Sundaresan seeks to leave a lasting impact on cancer treatment and patient care, shaping the future of oncology research.

Citations

A total of  496 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations            496
  • h-index              11
  • i10-index           12

Notable Publications 

S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis
S Sundaresan, P Subramanian
[105] 2003

Prevalence of anemia in the school children of Kattankulathur, Tamil Nadu, India
B Sudhagandhi, S Sundaresan, WE William, A Prema
[90] 2011

Prevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by S-allylcysteine
S Sundaresan, P Subramanian
[54] 2008

The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma
R Padma, A Kalaivani, S Sundaresan, P Sathish
[51] 2017

Hepatoprotective activity of Boerhavia diffusa L.(Nyctaginaceae) against ibuprofen induced hepatotoxicity in wistar albino rats
A Jayavelu, A Natarajan, S Sundaresan, K Devi, B Senthilkumar
[28] 2013

Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis …
B Prabhu, D Balakrishnan, S Sundaresan
[24] 2016

Evaluation of chemopreventive potential of garlic extract on N-nitrosodiethylamine-induced hepatocarcinoma in rats
S Sundaresan, P Subramanian
[21]  2002

Synergistic anti-carcinogenic effect of interferon-β with cisplatin on human breast adenocarcinoma MDA MB231 cells
P Ethiraj, K Veerappan, B Doraisami, S Sivapatham
[14] 2014

Squamous cell carcinoma of buccal mucosa: Prevalence of clinicopathological pattern and its implications for treatment
R Padma, S Paulraj, S Sundaresan
[13] 2017

Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells
P Ethiraj, K Veerappan, S Samuel, S Sivapatham
[13] 2016

Benjamin De Becker | Cardiologie and Electrophysiology | Best Researcher Award

Dr. Benjamin De Becker | Cardiologie and Electrophysiology | Best Researcher Award

AZ Sint Jan, Belgium

Author Profile

Early Academic Pursuits:

Dr. Benjamin De Becker embarked on his academic journey at the Université libre de Bruxelles (ULB), where he earned his Bachelor and Master's degrees in Medicine from 2006 to 2013. During this period, he also engaged in clinical research, focusing on the effects of acute diesel exhaust on pulmonary hemodynamics, earning him the highest distinctions and congratulations from the jury.

Professional Endeavors:

Following his medical education, He pursued a Master's in Internal Medicine from 2013 to 2016 and a subsequent Master's in Cardiology from 2016 to 2021 within the ULB hospitals network. His commitment to cardiology continued with a Fellowship in Electrophysiology and pacing at AZ Sint Jan Brugge from 2021 till the present, demonstrating a dedicated focus on specialized areas within the field.

Contributions and Research Focus:

His research has been prolific, with a current focus on electrophysiology. From 2017 to 2021, his research delved into hypouricemia and cardiovascular outcomes, exploring aspects such as endothelial function, arterial stiffness, and oxidative stress. Supported by various grants, including those from FNRS, Fonds Erasme, and Fondations Roi Baudouin, his work has made substantial contributions to understanding the connections between uric acid levels and cardiovascular health.

Accolades and Recognition:

The numerous awards and grants received by Dr. De Becker underscore his excellence in the field. Noteworthy mentions include the Best Poster Presentation at BHRM 2023, the Chapman Award in 2021, and multiple grants from prestigious institutions like FNRS and Fonds pour la chirurgie cardiaque.

Impact and Influence:

With an impressive citation index of 289 in Scopus/Web of Science/PubMed, His work has left a significant impact on the academic community. His research, publications, and awards collectively demonstrate his influence within the realm of cardiology and electrophysiology.

Legacy and Future Contributions:

His journey is marked by a commitment to research excellence, evident in his ongoing projects, publications, and academic achievements. His legacy is one of dedication to advancing knowledge in cardiology, and his future contributions are eagerly anticipated, particularly as he pursues a Ph.D. with an expected thesis completion in 2022. As a Doctor in Cardiology specializing in Electrophysiology, his expertise promises continued positive contributions to the field.

Citations

A total of  289 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations            289
  • h-index              7
  • i10-index           23

Notable Publications 

Interaction between left bundle branch area pacing lead and defibrillator lead: A case report
François, C., De Becker, B., De Smet, M., ...Tavernier, R., le Polain de Waroux, J.-B

Esophageal Ulceration in a Large Contemporary Patient Cohort Undergoing Radiofrequency PVI With Maximal Preventive Measures
De Smet, M.A.J., Wielandts, J.-Y., De Becker, B., ...Knecht, S., Duytschaever, M

No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients with Persistent Atrial Fibrillation: Results from the POWDER-AF2 Trial
Demolder, A., O'Neill, L., El Haddad, M., ...Tavernier, R., Duytschaever, M.

Impact of Catheter Ablation on Arrhythmia Burden in Patients With Shock-Resistant Persistent Atrial Fibrillation
O'Neill, L., Almorad, A., El Haddad, M., ...Duytschaever, M., Knecht, S.

Cardiac resynchronization therapy using conduction system pacing after double-switch surgery for congenitally corrected transposition of the great arteries: a case report
De Becker, B., O'neill, L., Pierard, S., Le Polain De Waroux, J.-B.

Very High-Power Ablation for Contiguous Pulmonary Vein Isolation: Results From the Randomized POWER PLUS Trial
O'Neill, L., El Haddad, M., Berte, B., ...Knecht, S., Duytschaever, M.

Septal coronary vein infringement during LBBAP
O’Neill, L., Gillis, K., Wielandts, J.-Y., ...Tavernier, R., Le Polain De Waroux, J.-B.

Evaluation of a standardized approach using optimized and contiguous RF applications for electrical isolation of the superior vena cava
Hilfiker, G., De Becker, B., Haddad, M.E., ...Duytschaever, M., Knecht, S.

Catheter Ablation of Persistent AF—Where are We Now?
O’Neill, L., De Becker, B., De Smet, M.A.J., ...Duytschaever, M., Knecht, S

Severe coronary spasm occurring remotely from pulsed field application during right inferior pulmonary vein isolation
De Becker, B., Francois, C., De Smet, M., ...Duytschaever, M., Knecht, S.